Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest JDRF Articles
Popular JDRF Articles
Highly Recommended JDRF Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Amylin, JDRF Team to Test Symlin/Insulin Combo for Type 1
Symlin and Insulin for Type 1's
Amylin Pharmaceuticals has announced that it will collaborate with the Juvenile Diabetes Research Foundation to test a combination of Symlin and insulin in injectible form as a type 1 therapy.
Currently, people with type 1 diabetes who take Symlin and insulin inject them separately. The test will determine if taking the two together increases blood sugar control by reducing the number of separate daily injections, making it easier for type 1s to manage the disease.
Symlin (pramlintide acetate) is an artificial analog of amylin, which is a hormone the pancreas secretes into the bloodstream along with insulin after a meal. In people with diabetes, amylin may be deficient or non-existent.
Symlin works by promoting a sense of satiety, slowing gastric emptying-which helps with the absorption of glucose-and inhibiting glucagon secretion.
The Amylin Pharmaceuticals-JDRF collaboration is the second one that the two partners have entered over the past year. In November, they announced that they would test whether metreleptin, a leptin mimic, can improve blood sugar control to the point of lowering the daily insulin dose required by patients with diabetes.
Categories: , Amylin Pharmaceuticals, Blood Glucose, Blood Sugar, Diabetes, Diabetes, Glucagon, Injection, JDRF, Symlin, Type 1 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...